Abstract:During fetal life and the transition to extra-uterine air breathing, pulmonary vascular tone is regulated by a complex, interactive group of mechanisms. Arachidonic acid metabolites play an important role in this regulation. Although prostaglandins may not be central to regulation of the resting fetal pulmonary circulation, PGI2 acts to modulate tone and thereby maintain pulmonary vascular resistance relatively constant. PGI2 also may play an important role as one of the components involved in the major changes that occur with the onset of air breathing. Leukotrienes, also metabolites of arachidonic acid and potent smooth muscle constrictors, may play an active role in maintaining the normally high fetal pulmonary vascular resistance, because leukotriene receptor blockade or synthesis inhibition increases pulmonary blood flow about eight-fold; the presence of leukotrienes in fetal tracheal fluid further supports this. In addition to PGI2, vascular endothelial cells produce other vasoactive factors. These include potent vasodilators, such as endothelium-derived relaxing factor (EDRF). EDRF, known to be nitric oxide (NO) and often called endothelium-derived nitric oxide (EDNO), is produced by endothelial cells in response to varied stimuli, generally involving specific receptors and the activation of endothelial NO synthetase (eNOS); subsequent smooth muscle relaxation is produced by a NO/guanylyl cyclase/cGMP-mediated mechanism. NO clearly is involved in regulation of vascular tone in the fetal pulmonary circulation, although it plays a far more important role in the postnatal transition to air breathing. Superfused fetal sheep pulmonary arteries release NO when stimulated with bradykinin. In fetal lambs the vasodilating effects of bradykinin are attenuated by methylene blue and resting tone falls with N(omega)-nitro-L-arginine, an inhibitor of NO synthesis, suggesting that a NO/cGMP-dependent mechanism continuously modulates or offsets the increased tone of the resting fetal pulmonary circulation. Inhibition of NO synthesis blocks the pulmonary vasodilation with oxygenation of fetal lungs in utero. Shear stress-induced NO production as well as the relationship of oxygenation to NO production further support the important function of NO in the transition. Although endothelin-1 (ET-1) has potent vasoactivity as well as ontogenetic differences in effect on pulmonary vascular resistance, its exact physiological role has not been defined. Adrenomedullin and calcitonin gene-related peptide (CGRP), two additional vasoactive substances, have profound, and prolonged, vasodilating effects in the fetal pulmonary circulation. Their physiological roles have not yet been established.

COX and the control of the pulmonary circulation

Involvement of COX-2 in Antagonism to Heme Oxygenase-1 on Cardioprotection from Anoxia/reoxygenation Induced Injury in Rats

Cyclo-Oxygenase 2 Up-Regulates the Effect of Multidrug Resistance

[Relationship Between Expression of Endothelial Nitric Oxide Synthase and NADPH Oxidase in Lungs of Mice Exposed to Chronic Hypoxia].

[COX-2 or Nnos Mediates Cardioprotection During the Final Stage of the Late Phase of Ischemic Preconditioning].

Regulation of Rat Intrapulmonary Arterial Tone by Arachidonic Acid and Prostaglandin E2 During Hypoxia

Predominant Role of Vasoconstrictors over Dilatators Derived from Arachidonic Acid in Hypoxic Pulmonary Vasoconstriction.

Carbon monoxide as an endogenous vascular modulator

Nitric Oxide Regulation of Myocardial O-2 Consumption and Hep Metabolism

Paracoxib Alleviates Ventilator-Induced Lung Injury Through Functional Modulation of Lung-Recruited CD11b<SUP>lo</SUP>Ly6C<SUP>hi</SUP> Monocytes

Reactive oxygen species mediate arachidonic acid-induced dilation in porcine coronary microvessels

The influence of pulmonary blood flow rate on vascular input impedance and hydraulic power in the sympathetically and noradrenaline stimulated cat lung

Cyclooxygenase products contribute to the exaggerated exercise pressor reflex evoked by static muscle contraction in male UCD-type 2 diabetes mellitus rats

Heme oxygenase-1 and carbon monoxide in pulmonary medicine

[Chronic Hypoxia Altered the Mrna Expression of Cyclooxygenase in Intrapulmonary Artery Smooth Muscle Cell].

Pulmonary Oxidative Stress Is Increased in Cyclooxygenase-2 Knockdown Mice with Mild Pulmonary Hypertension Induced by Monocrotaline

Control of the pulmonary circulation in the fetus and during the transitional period to air breathing

The Regulating Effect of Heme Oxygenase/carbon Monoxide on Hypoxic Pulmonary Vascular Structural Remodeling

Oxygen conditions oscillating between hypoxia and hyperoxia induce different effects in the pulmonary endothelium compared to constant oxygen conditions

Hypoxic pulmonary vasoconstriction as a regulator of alveolar-capillary oxygen flux: A computational model of ventilation-perfusion matching

Renal function underpins the cyclooxygenase-2: ADMA axis in mouse and man